Fernwood Investment Management, LLC Cytokinetics Inc Transaction History
Fernwood Investment Management, LLC
- $303 Million
- Q3 2024
A detailed history of Fernwood Investment Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Fernwood Investment Management, LLC holds 10,000 shares of CYTK stock, worth $492,000. This represents 0.17% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$492,000
Previous $541,000
2.4%
% of portfolio
0.17%
Previous 0.17%
Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
405Shares Held
125MCall Options Held
4.61MPut Options Held
2.46M-
Black Rock Inc. New York, NY14.7MShares$722 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$579 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$477 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$383 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$318 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.63B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...